BBOT vs NIO · rev $7.5M vs rev $12.51B
BridgeBio Oncology Therapeutics, Inc. (BBOT) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Latest reported BBOT revenue for 2026-06-30 was $7.5M. Net income was -$98.6M. Revenue was up 90.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
BBOT currently screens at market cap $610.4M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the BBOT and NIO stock pages for the full models.
Not investment advice.